Gilead Sciences's market cap is currently $122.71B. The company's EPS TTM is CHF1.9980812072000003; its P/E ratio is 13.06; and it has a dividend yield of 2.79%. Gilead Sciences is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is CHF1.55. See an overview of income statement, balance sheet, and cash flow financials.
